A birth defect or birth irregularity occurs during the time of the baby’s development in utero. It is believed that most infant birth irregularities take place during the first three months of pregnancy. Out of 33 babies born in America, one baby will be born with some type of irregularity or defect.
A birth defect can affect how the baby’s body functions, looks or even both. Birth irregularities like cleft lip or cleft palate are easier to identify, unlike others that are hard to detect without tests. What causes birth defects varies and can be the result of medical malpractice all the way to defective drugs that a mother takes while pregnant.
The drug Zofran, is a drug that has been highlighted as one that can cause specific birth irregularities if taken by an expectant mom in the first trimester of her pregnancy. Expectant mothers have been known to consume Zofran for severe morning sickness on the advise of their doctors who recommend it to stop severe nausea and vomiting (NVM). However, Zofran was not created for use in pregnant women, it was created for use in cancer patients going through chemo and radiation therapy as well as those afflicted with NVM due to a post medical procedure. The makers of Zofran GlaxoSmithKline (GSK) have not carried out adequate tests for this particular use of their drug. There have been studies conducted to see the effects Zofran has on an unborn baby and these studies have shown that Zofran sharply increases the chances of a baby being born with certain abnormalities including cleft palate and congenital heart abnormalities. For more information about the studies go here.
As a consequence of GSK’s misrepresentation of their drug, many lawsuits have since been filed alleging that Zofran was the cause of infant birth irregularities because a mom used Zofran in order to relieve severe morning sickness she was suffering in the first 12 weeks of pregnancy.
Rates Of Infant Birth Abnormalities In Oregon
Oregon.gov states that The Oregon Public Health Division is joining the National Birth Defects Prevention Network (NBDPN) to increase awareness of birth defects, the leading cause of infant deaths in the United States. It’s reported that every 4½ minutes, a baby is born with a birth defect in America. It is documented that for every 33 babies born in America one is born with an abnormality. In 2014 the number of people living in Oregon was registered as 3,970,239. Of that number, the following are the five most highly inhabited cities in Oregon State:
- Portland- 619,360 population
- Salem- 161,637 population
- Eugene- 160,561 population
- Gresham- 109,892 population
- Hillsboro- 99,393 population
Taking into account that Zofran was readied for public usage in 1991, the drug swiftly became the most popular drug in written scripts. Zofran was so well known that it had 99% market share by 2005. By further employing the number of birth defects in all of America of one out every 33, our Zofran advocates have been able to work out probable figures of births where Zofran would have been a birth abnormality cause agent, as well as incorporating the risk ratios established in the various clinical studies accomplished. We have calculated a probable figure of 2,360 infant births in Oregon that were affected by the presence of Zofran in utero culminating into a birth abnormality.
Possible Data About Zofran Associated Cleft Palate And Congenital Heart Abnormalities In Oregon
Based on the Oregon population of 3,970,239, our estimations show that there were, 422 infant birth abnormalities in the form of a cleft palate, and 1,938 births with a congenital heart abnormality. Looking at Oregon’s five major cities from above, the cleft palate and congenital heart abnormalities come out as follows:
- Portland- 340 infant birth abnormality with generally 108 clef palate, and 232 congenital heart abnormalities
- Salem- 126 infant birth abnormality with generally 15 cleft palate, and 111 congenital heart abnormalities
- Eugene- 125 infant birth abnormality with generally 15 cleft palate, and 110 congenital heart abnormalities
- Gresham- 102 infant birth abnormality with generally 11 cleft palate, and 91 congenital heart abnormalities
- Hillsboro- 97 infant birth abnormality with generally 10 cleft palate, and 87 congenital heart abnormalities
Known & Documented Infant Deformities
CDC and Sloan Epidemiology piloted a study about the effects of Zofran on an unborn baby. Their results revealed that there is a possible rise of 2.37 chance of an infant being born with a cleft palate in instances where a mother used Zofran to alleviate morning sickness in the first 12 weeks of pregnancy. There has already been a lawsuit filed for Zofran causing cleft palate in an infant. Read about the lawsuit here.
Regardless of this clinical evidence as well as filed lawsuits, GSK, does not acknowledge these facts. However, filed lawsuits further reveal that some of these defects or deformities were caused by a mother taking Zofran:
- Atrial septal defect
- Ventricular septal defect
- Renal deformities
- Webbed toes
- Low set ears
- Bicuspid aortic stenosis
- Heart murmur
- Facial dysmorphia
- Cleft palate
- Club foot
Oregon Parents Searching For Justice
This website, ZofranLegal.com, is financed by a number of law firms with the intention of the website providing up to date information about the Zofran lawsuit. Our Zofran advocacy team is not certified to practice law in Oregon State, but we are certified to practice law and hold offices in the state of Delaware. Delaware is a state of particular importance to this litigation as it is where GlaxoSmithKline has its HQ. What this means for you is that we are authorized to represent your case in Delaware. For our office information, go here.
In order to file your litigation we may advise you to file in Delaware State or at another applicable place. We have a good network of known Oregon counsel that we would recommend for you to file with them as well if your case circumstances allow for Oregon filing.
We understand that you may have a lot of questions at this stage and we encourage you to call us at any time to speak to us about your case. Go here to learn more about our Zofran advocates.